[On the use of muscle relaxants, especially chlorzoxazone (Paraflex) in the field of rehabilitation programs].
D002317:Cardiovascular Agents; D002753:Chlorzoxazone; D004194:Disease; D005116:Extrapyramidal Tracts; D006801:Humans; D009103:Multiple Sclerosis / Q000628:therapy*; D009128:Muscle Spasticity / Q000628:therapy*; D010243:Paralysis / Q000628:therapy*; D013122:Spinal Diseases; D013131:Spine; D015049:Zoxazolamine / Q000031:analogs & derivatives
D002317:Cardiovascular Agents; D015049:Zoxazolamine; D002753:Chlorzoxazone
EXTRAPYRAMIDAL TRACTS/diseases; MULTIPLE SCLEROSIS/therapy; PARALYSIS, SPASTIC/therapy; SPINE/diseases; ZOXAZOLAMINE/related compounds